TIRZEPATIDE — 60 MG

Tirzepatide is a long-acting peptide that functions as a dual GIP and GLP-1 receptor agonist. It is the active ingredient in FDA-approved prescription products used for type 2 diabetes and chronic weight management. By activating these two incretin pathways, tirzepatide can improve glucose-dependent insulin signaling, reduce appetite and caloric intake, and slow gastric emptying.

Key effects and benefits include:

• Significant reduction in appetite and food intake
• Clinically demonstrated weight loss
• Improved blood-glucose control and insulin sensitivity
• Improved metabolic markers in appropriate patients
• Dual GIP + GLP-1 receptor activity
• Long duration of action that supports once-weekly prescription dosing

Common adverse effects are primarily gastrointestinal, including nausea, diarrhea, constipation, vomiting, abdominal discomfort, and decreased appetite. Tirzepatide also has important contraindications and warnings, so actual treatment should be managed through an appropriate healthcare professional.

60 MG TOTAL PER VIAL.